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In Campylobacter jejuni, a Gram-negative bacterial pathogen causing gastro-
enteritis in humans, the CmeR regulatory protein controls transcription of the
multidrug transporter gene operon cmeABC. CmeR belongs to the TetR family
of transcriptional regulators. The 210-residue CmeR consists of two functional
motifs: an N-terminal DNA-binding domain and a C-terminal ligand-binding
domain. It is predicted that the DNA-binding domain interacts directly with
target promoters, while the C-terminal motif interacts with inducing ligands
(such as bile salts). As an initial step towards confirming this structural model,
recombinant CmeR protein containing a 6His tag at the N-terminus was
crystallized. Crystals of ligand-free CmeR belonged to space group P21212, with
unit-cell parameters a = 37.4, b = 57.6, c = 93.3 A˚. Diffraction was observed to at
least 2.2 A˚ at 100 K. Analysis of the detailed CmeR structure is currently in
progress.
1. Introduction
Campylobacter jejuni is the leading bacterial cause of foodborne
diarrhea in the United States and other developed countries
(Friedman et al., 2000). It is also a significant enteric pathogen for
young children in developing countries. This Gram-negative enteric
organism colonizes the intestinal tracts of animals and has become
increasingly resistant to antimicrobials owing to its possession of
multidrug efflux transporters and its acquisition of various resistance
mechanisms, compromising the effectiveness of antibiotic treatment.
According to the genomic sequence of NCTC 11168, C. jejuni harbors
13 putative antibiotic efflux transporters of the ATP-binding cassette
(ABC), resistance–nodulation–division (RND), multidrug and toxic
compound extrusion (MATE), major facilitator (MF) and small
multidrug-resistance (SMR) families (Parkhill et al., 2000; Lin, Akiba
& Zhang, 2005). At present, CmeABC and CmeDEF, which belong to
the RND family, are the only two antibiotic efflux transporters that
have been functionally characterized in Campylobacter (Akiba et al.,
2006; Lin et al., 2002; Pumbwe & Piddock, 2002).
The CmeABC efflux system consists of three members, including
an outer membrane channel (CmeC), an inner membrane drug
transporter (CmeB) and a periplasmic membrane-fusion protein
(CmeA). These three proteins are encoded by a three-gene operon
(cmeABC) and form an efflux system that extrudes a variety of toxic
compounds directly out of C. jejuni (Lin et al., 2002). The substrates
extruded by CmeABC include commonly used antibiotics (e.g.
fluoroquinolones, macrolides, ampicillin, tetracycline, chlor-
amphenicol, cefotaxime and rifampin), ions (e.g. Co2+ and Cu2+) and
lipophilic compounds (e.g. SDS and various bile salts). Thus,
CmeABC contributes significantly to the intrinsic and acquired
resistance of Campylobacter to structurally diverse antimicrobials
(Cagliero et al., 2005; Lin et al., 2002; Luo et al., 2003; Pumbwe &
Piddock, 2002). In addition, this efflux system is also essential for
Campylobacter colonization of the animal intestinal tract by confer-
ring resistance to bile acids (Lin et al., 2003), which are normally
present in the animal intestinal tract and have bactericidal effect.
The expression of cmeABC is controlled by the transcriptional
regulator CmeR (Lin, Akiba, Sahin et al., 2005). The cmeR gene is
located immediately upstream of the cmeABC operon and encodes a
210-residue protein that shares N-terminal sequence and structural
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similarities with members of the TetR family of transcriptional
repressors (Grkovic et al., 2002; Ramos et al., 2005). Like other
members of the TetR family, the N-terminal domain of CmeR
contains a predicted DNA-binding helix–turn–helix (HTH) motif,
while its C-terminal region contains unique sequences and is
expected to be involved in the binding of inducing ligands (Grkovic et
al., 2002; Lin, Akiba, Sahin et al., 2005). cmeR is transcribed in the
same direction as cmeABC and the intergenic region between cmeR
and cmeA contains the inverted-repeat (IR) operator site for
cmeABC. As a transcriptional regulator, CmeR binds directly to the
IR operator and represses the transcription of cmeABC (Lin, Akiba,
Sahin et al., 2005). Deletion of cmeR or mutations in the IR operator
release the repression, resulting in the overexpression of CmeABC,
which in turn leads to the enhanced resistance to multiple antibiotics.
In addition, bile compounds, including both conjugated (e.g. tauro-
deoxycholate) and nonconjugated (e.g. cholate), induce the expres-
sion of cmeABC by inhibiting the binding of CmeR to the promoter
of cmeABC (Lin, Cagliero et al., 2005), suggesting that bile
compounds are inducing ligands of CmeR.
The hypothesis is that binding of inducing ligands to the C-terminal
domain of CmeR triggers conformational change in the N-terminal
DNA-binding region. This change in conformation results in the
release of CmeR from its operator DNA and thus allows transcrip-
tion from its cognate promoter. As an initial step to elucidate the
mechanisms that CmeR uses to regulate gene expression, we here
report the crystallization and preliminary X-ray diffraction analysis of
the CmeR repressor.
2. Materials and methods
2.1. Protein purification and crystallization
Recombinant CmeR was produced in Escherichia coli using the
pQE30 vector (Qiagen). The cloning, expression and purification
procedures have been described previously (Lin et al., 2002, 2003;
Lin, Akiba, Sahin et al., 2005). This recombinant CmeR, containing a
6His tag at the N-terminus, is fully functional in DNA binding in
vitro and is inducible by bile salts. After purification, the purity of the
protein was judged using 10% SDS–PAGE stained with Coomassie
Brilliant Blue. The purified protein was extensively dialyzed against
buffer containing 10 mM sodium phosphate pH 7.2 and 100 mMNaCl
and then concentrated to 10 mg ml1.
Selenomethionyl-CmeR (SeMet-CmeR) containing a 6His tag at
the N-terminus was overproduced in E. coli JM109 cells. Briefly, a
10 ml LB overnight pre-culture was transferred into 100 ml LB
medium containing 100 mg ml1 ampicillin. The cell culture was
grown at 310 K and 210 rev min1. When the OD600 value was around
1.2, cells were harvested by centrifugation at 6000 rev min1 for
10 min and then washed two times with 5 ml M9 solution. The cells
were resuspended in 10 ml M9 solution and then transferred into 1 l
pre-warmed M9 solution containing 100 mg ml1 ampicillin. The cell
culture was incubated at 310 K and 210 rev min1. When the OD600
reached 0.4, 100 mg lysine, phenylalanine and threonine, 50 mg
isoleucine, leucine and valine and 60 mg l-selenomethionine were
added. The culture was induced with 1 mM IPTG after 15 min. Cells
were harvested within 4 h and were frozen and stored at 193 K. The
purification procedure for the SeMet-CmeR protein was the same as
that for native CmeR. The 210-amino-acid CmeR contains three
methionines; replacement of these methionine sulfurs with seleniums
in the SeMet-CmeR protein was confirmed by MALDI time-of-flight
mass spectrometry.
The 6His CmeR protein was crystallized in 24-well plates using
the hanging-drop vapor-diffusion method at 293 K. Initial crystal-
lization screening was performed using commercially available
sparse-matrix screens (Jancarik & Kim, 1991) from Hampton
Research. Briefly, a 2 ml mixture consisting of 1 ml protein solution
(10 mg ml1 CmeR in 10 mM sodium phosphate pH 7.2 and 100 mM
NaCl) and 1 ml reservoir solution was equilibrated against 500 ml
reservoir solution. Crystals of CmeR appeared within two weeks.
After optimization, the best native 6His CmeR crystals were
obtained from reservoir solution containing 22% PEG 4000, 0.1M
Tris pH 8.5, 0.2M MgCl2 and 4% glycerol. Cryoprotection was
achieved by raising the PEG 4000 concentration stepwise to 35% with
a 5% increment in each step. Crystals of the SeMet-CmeR protein
were grown under the same conditions.
2.2. Data collection and processing
For data collection, a single native crystal was flash-cooled in a
cryoprotectant solution containing 35% PEG 4000, 7% glycerol,
0.2M MgCl2 and 0.1M Tris buffer pH 8.5 at 100 K. The best
diffraction of the native CmeR crystal was obtained to at least 2.2 A˚
resolution at a cryogenic temperature of 100 K using a synchrotron
light source (Table 1). Multiple-wavelength anomalous diffraction
(MAD) data were collected from a single SeMet-CmeR crystal to a
crystallization communications
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Table 1
Data collection and crystallographic analysis of CmeR.
Values in parentheses are for the highest resolution shell.
SeMet
Native
Inflection
point Peak Remote
Data collection
Wavelength (A˚) 0.9795 0.9798 0.9795 0.9662
Space group P21212 P21212
Unit-cell parameters
(A˚)
a = 37.4,
b = 57.6,
c = 93.3
a = 37.3, b = 57.5, c = 93.0
Resolution (A˚) 2.24
(2.33–2.24)
2.10
(2.18–2.10)
2.07
(2.28–2.07)
2.07
(2.14–2.07)
Completeness (%) 99.6 (97.7) 97.6 (85.1) 93.4 (84.1) 97.2 (80.3)
Total No. of reflections 297224 168174 179712 179712
No. of unique reflections 10172 12493 14087 12897
Rsym (%) 5.5 (26.2) 5.8 (25.0) 5.2 (26.4) 5.1 (27.3)
Average I/(I) 16.6 (4.7) 23.3 (3.8) 22.3 (5.3) 18.2 (3.2)
Phasing
Se-atom sites 3
Resolution range of
data used (A˚)
50–2.80
Overall figure of merit 0.59
Figure 1
Image of the CmeR crystal. The native crystal was grown using 22% PEG 4000,
0.1M Tris pH 8.5, 0.2M MgCl2 and 4% glycerol.
maximum resolution of 2.1 A˚ (Table 1). Diffraction data sets from
both the native and SeMet-CmeR crystals were taken at the
Advanced Light Source (beamline 8.2.2) at cryogenic temperature
(100 K) using an ADSC Quantum 315 CCD-based detector. The
beam size was 140  150 mm. Diffraction data sets were processed
with DENZO and scaled with SCALEPACK (Otwinowski & Minor,
1997).
3. Results and discussion
Using hanging-drop vapor diffusion, we have successfully grown a
large quantity of CmeR crystals. The dimensions of the crystals were
typically 0.4  0.4  0.1 mm (Fig. 1). The crystals of 6His CmeR
belonged to space group P21212, with unit-cell parameters a = 37.4,
b = 57.6, c = 93.3 A˚,  =  =  = 90.
The SeMet crystal belonged to space group P21212, with unit-cell
parameters very similar to those of the native crystal (Table 1). The
three-wavelength anomalous dispersion (MAD) data were scaled
with SCALEPACK (Otwinowski & Minor, 1997). Phase calculation
was carried out at 2.8 A˚ resolution using the program BnP (Weeks et
al., 2005) after finding and refinement of all three selenium sites. The
electron-density map obtained was improved by density modification
(DM) using RESOLVE (Terwilliger, 2001). Fig. 2 shows the MAD
electron-density map improved by DM and the initial C protein
trace.
The available structures of members of the TetR family of tran-
scriptional repressors, including those of TetR (Hinrichs et al., 1994;
Orth et al., 2000), QacR (Schumacher et al., 2001, 2002), CprB
(Natsume et al., 2003) and EthR (Dover et al., 2004; Frenois et al.,
2004), indicate that all these repressors assemble as dimers. Recently,
the preliminary X-ray diffraction data of AcrR (another member of
the TetR family) also suggest a dimeric assembly of the repressor (Li
et al., 2006). Thus, it is likely that the structure of CmeR is also
dimeric.
The MC program (Matthews, 1968, 1977) from the CCP4 package
(Collaborative Computational Project, Number 4, 1994) suggests that
the crystals are likely to contain one CmeR monomer in the asym-
metric unit, which gives a Matthews value VM of 2.0 A˚
3 Da1 and a
solvent content of 36.9%. By applying the crystallographic symmetry
operators, a dimeric arrangement of the protein was found. Analysis
of the structure is currently in progress.
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Figure 2
MAD electron-density map of CmeR contoured at 1. The C plot of one subunit
of CmeR is shown in yellow.
